Navigation Links
Master regulator found for regenerating nerve fibers in live animals
Date:10/25/2009

Boston, Mass. -- Researchers at Children's Hospital Boston report that an enzyme known as Mst3b, previously identified in their lab, is essential for regenerating damaged axons (nerve fibers) in a live animal model, in both the peripheral and central nervous systems. Their findings, published online by Nature Neuroscience on October 25, suggest Mst3b or agents that stimulate it as a possible means of treating stroke, spinal cord damage and traumatic brain injury. Normally, neurons in the central nervous system (the brain and spinal cord) cannot regenerate injured nerve fibers, limiting people's ability to recover from brain or spinal cord injuries.

The study, led by Nina Irwin, PhD and Larry Benowitz, PhD, of the Laboratories for Neuroscience Research in Neurosurgery and the F.M. Kirby Neurobiology Center at Children's, builds on previous discoveries in the lab. In 2002, they showed that a naturally occurring small molecule, inosine, stimulates axon regeneration, later showing that it helps restore neurological functions in animal models of injury. In 2006, Benowitz and colleagues reported a previously unknown growth factor, oncomodulin, to have dramatic effects on axon growth.

Investigating the mechanisms of action of inosine and oncomodulin, Irwin and Benowitz discovered that both compounds activate Mst3b, an enzyme that appears to be a master regulator of a cell-signaling pathway controlling axon growth. Mst3b, a protein kinase, in turn activates signals that switch on the genes necessary for axons to grow.

Working with live rats whose optic nerve was damaged (a common model of central-nervous-system injury), Irwin, Benowitz and colleagues show that in the absence of Mst3b, axons show very little regeneration, even in the presence of factors known to enhance axon growth. In cell cultures, axon growth increased when activated Mst3b was expressed in the neurons.

"All the growth factors we've tested oncomodulin, inosine, brain-derived neurotropic factor, nerve growth factor act through Mst3b," says Benowitz. "In fact, activating Mst3b by itself is enough to cause growth even if there are no growth factors around. In terms of basic understanding of nerve cells, this is a very exciting finding."

Further studies examining how Mst3b exerts this growth-promoting effect may open up new avenues for treating brain and spinal cord injuries, Benowitz says. While this study explains why growth factors work because they stimulate Mst3b it's not yet known whether Mst3b is the best stimulator of axon growth from a practical drug-development standpoint, he adds.

Irwin is now working on possible gene therapy approaches involving Mst3b. Activating Mst3b may help overcome some natural "brakes" in the cell-signaling system that prevent nerve regeneration under normal conditions.


'/>"/>

Contact: James Newton
james.newton@childrens.edu
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Related biology news :

1. New research network at McMaster aims to build a better eye
2. Master gene that switches on disease-fighting cells identified by scientists
3. Suppressing cancer with a master control gene
4. McMaster researchers discover new mode of how diseases evolve
5. Master gene plays key role in blood sugar levels
6. New book helps medical students master clinical skills
7. New master switch found in the brain that regulates appetite and reproduction
8. McMaster University engineering professor receives Humboldt Research Award
9. Master Lock(R) smartTOUCH(TM) Garage Door Opener to be Featured on Hispanic Network Radio Weekend Show
10. Bits of junk RNA aid master tumor-suppressor gene
11. Regulatory role of key molecule discovered at Hebrew U.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2016)... VILNIUS, Lithuania , Nov. 21, 2016 /PRNewswire/ ... identification and object recognition technologies, today announced that ... for smart cards was submitted for the ... and successfully passed all the mandatory steps of ... III evaluation is a continuing test of fingerprint ...
(Date:11/17/2016)... it has just released a new white paper authored by Zettar that covers the ... transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a complicated endeavor ...
(Date:11/15/2016)... 15, 2016 Research and Markets has announced ... 2021" report to their offering. ... ... by 2021 from USD 6.21 Billion in 2016, growing at a ... of the bioinformatics market is driven by the growing demand for ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
(Date:12/4/2016)... ... December 02, 2016 , ... ... and -operated small businesses in federally funded research and development is welcome news ... for optics and photonics . , As part of the National Defense Authorization ...
(Date:12/4/2016)... and CAMBRIDGE, Mass. and ... Dec. 4, 2016 SystemOne, a company ... software platforms for the developing world, and Daktari ... a reality with its portable and ultrasensitive immunoassay-based ... a development and license agreement to integrate Daktari,s ...
(Date:12/2/2016)... NORWALK, Conn. , Dec. 2, 2016  The ... research presentations from the MMRF CoMMpass Study SM —the ... and accelerating precision medicine in multiple myeloma—will be presented ... (ASH) Annual Meeting & Exposition in San ... are helping to optimize treatment strategies, as well as ...
Breaking Biology Technology: